Department of Applied Chemistry, School of Applied Chemical Engineering, Kyungpook National University, Daegu 41566, Korea.
Int J Mol Sci. 2019 May 10;20(9):2323. doi: 10.3390/ijms20092323.
In the last two decades, various nanomaterials have attracted increasing attention in medical science owing to their unique physical and chemical characteristics. Incorporating radionuclides into conventionally used nanomaterials can confer useful additional properties compared to the original material. Therefore, various radionuclides have been used to synthesize functional nanomaterials for biomedical applications. In particular, several α- or β-emitter-labeled organic and inorganic nanoparticles have been extensively investigated for efficient and targeted cancer treatment. This article reviews recent progress in cancer therapy using radiolabeled nanomaterials including inorganic, polymeric, and carbon-based materials and liposomes. We first provide an overview of radiolabeling methods for preparing anticancer agents that have been investigated recently in preclinical studies. Next, we discuss the therapeutic applications and effectiveness of α- or β-emitter-incorporated nanomaterials in animal models and the emerging possibilities of these nanomaterials in cancer therapy.
在过去的二十年中,由于其独特的物理和化学特性,各种纳米材料在医学领域引起了越来越多的关注。将放射性核素掺入传统使用的纳米材料中,可以赋予比原始材料更有用的附加特性。因此,已经使用各种放射性核素来合成用于生物医学应用的功能性纳米材料。特别是,已经广泛研究了几种α或β发射体标记的有机和无机纳米粒子,以实现高效和靶向的癌症治疗。本文综述了使用放射性标记的纳米材料(包括无机、聚合和基于碳的材料和脂质体)进行癌症治疗的最新进展。我们首先概述了最近在临床前研究中研究过的用于制备抗癌剂的放射性标记方法。接下来,我们讨论了α或β发射体掺入纳米材料在动物模型中的治疗应用和有效性,以及这些纳米材料在癌症治疗中的新可能性。